LUNELLE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lunelle, and when can generic versions of Lunelle launch?
Lunelle is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in LUNELLE is estradiol cypionate; medroxyprogesterone acetate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol cypionate; medroxyprogesterone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LUNELLE?
- What are the global sales for LUNELLE?
- What is Average Wholesale Price for LUNELLE?
Summary for LUNELLE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 8 |
| Clinical Trials: | 1 |
| Patent Applications: | 2 |
| DailyMed Link: | LUNELLE at DailyMed |
Recent Clinical Trials for LUNELLE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sun Pharmaceutical Industries Limited | Phase 1/Phase 2 |
US Patents and Regulatory Information for LUNELLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | LUNELLE | estradiol cypionate; medroxyprogesterone acetate | INJECTABLE;INTRAMUSCULAR | 020874-001 | Oct 5, 2000 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
